Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression
Yi He(Central South University), Gangadhara R. Sareddy(The University of Texas Health Science Center at San Antonio)
Cited by 5
Related Papers
Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma
|Cell Death and Disease|2018|192
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
|Scientific Reports|2016|71
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer
|Cancer Letters|2021|19